Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Romain Marignier

Showing results (71-80 of 217) with videos related to

Pageof 22
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 8, 2020
Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibodyRomain Deschamps, Manon Philibert, Cedric Lamirel, et al.
Cell Reports|June 27, 2019
Aquaporin-4 Surface Trafficking Regulates Astrocytic Process Motility and Synaptic Activity in Health and Autoimmune DiseaseSilvia Ciappelloni, Delphine Bouchet, Nadège Dubourdieu, et al.
Annals of Neurology|April 25, 2017
Multiple sclerosis broke my heartGéraldine Androdias, Emilien Bernard, Damien Biotti, et al.
European Journal of Neurology|February 20, 2025
Long-Term Outcome and Prognosis of Idiopathic Optic Neuritis: A Cohort StudyBenjamin Leger, Antoine Gueguen, Augustin Lecler, et al.
Archives of Neurology|May 12, 2010
Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?Romain Marignier, Florian Chenevier, Veronique Rogemond, et al.
Brain : a Journal of Neurology|August 7, 2010
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injuryRomain Marignier, Adeline Nicolle, Chantal Watrin, et al.
Journal of Neurology|May 26, 2025
Clinical course and long-term outcomes in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathyJoaquín Arzalluz-Luque, Pauline Dumez, Géraldine Picard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2023
Anti-Argonaute antibodies as a potential biomarker in NMOSDSara Carta, Do Le Duy, Veronique Rogemond, et al.
Plos One|November 14, 2013
An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assaysRomana Höftberger, Lidia Sabater, Romain Marignier, et al.
Annals of Clinical and Translational Neurology|May 12, 2026
Efficacy of Inebilizumab in N-MOmentum Trial Participants With or Without Prior ImmunosuppressantsBruce A C Cree, Beatrice Suero, Sarah Walsh, et al.
Pageof 22

Showing results (71-80 of 217) with videos related to

Sort By:
Pageof 22
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 8, 2020
Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibodyRomain Deschamps, Manon Philibert, Cedric Lamirel, et al.
Cell Reports|June 27, 2019
Aquaporin-4 Surface Trafficking Regulates Astrocytic Process Motility and Synaptic Activity in Health and Autoimmune DiseaseSilvia Ciappelloni, Delphine Bouchet, Nadège Dubourdieu, et al.
Annals of Neurology|April 25, 2017
Multiple sclerosis broke my heartGéraldine Androdias, Emilien Bernard, Damien Biotti, et al.
European Journal of Neurology|February 20, 2025
Long-Term Outcome and Prognosis of Idiopathic Optic Neuritis: A Cohort StudyBenjamin Leger, Antoine Gueguen, Augustin Lecler, et al.
Archives of Neurology|May 12, 2010
Metabotropic glutamate receptor type 1 autoantibody-associated cerebellitis: a primary autoimmune disease?Romain Marignier, Florian Chenevier, Veronique Rogemond, et al.
Brain : a Journal of Neurology|August 7, 2010
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injuryRomain Marignier, Adeline Nicolle, Chantal Watrin, et al.
Journal of Neurology|May 26, 2025
Clinical course and long-term outcomes in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathyJoaquín Arzalluz-Luque, Pauline Dumez, Géraldine Picard, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 22, 2023
Anti-Argonaute antibodies as a potential biomarker in NMOSDSara Carta, Do Le Duy, Veronique Rogemond, et al.
Plos One|November 14, 2013
An optimized immunohistochemistry technique improves NMO-IgG detection: study comparison with cell-based assaysRomana Höftberger, Lidia Sabater, Romain Marignier, et al.
Annals of Clinical and Translational Neurology|May 12, 2026
Efficacy of Inebilizumab in N-MOmentum Trial Participants With or Without Prior ImmunosuppressantsBruce A C Cree, Beatrice Suero, Sarah Walsh, et al.
Pageof 22